.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fuji
AstraZeneca
Baxter
Federal Trade Commission
Boehringer Ingelheim
Merck
Chinese Patent Office
Cipla
Accenture

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205755

« Back to Dashboard
NDA 205755 describes ZYKADIA, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the ZYKADIA profile page.

The generic ingredient in ZYKADIA is ceritinib. One supplier is listed for this compound. Additional details are available on the ceritinib profile page.

Summary for NDA: 205755

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 205755

Mechanism of ActionTyrosine Kinase Inhibitors
Cytochrome P450 3A Inhibitors
Cytochrome P450 2C9 Inhibitors

Suppliers and Packaging for NDA: 205755

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYKADIA
ceritinib
 CAPSULE;ORAL 205755 NDA Novartis Pharmaceuticals Corporation 0078-0640 0078-0640-70 70 CAPSULE in 1 BOTTLE (0078-0640-70)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Apr 29, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:May 26, 2020
Regulatory Exclusivity Use:
Patent:7,153,964Patent Expiration:Feb 26, 2021Product Flag?YSubstance Flag?YDelist Request?
Patent:7,893,074Patent Expiration:Apr 25, 2026Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Covington
Accenture
Chinese Patent Office
Moodys
Colorcon
Boehringer Ingelheim
Daiichi Sankyo
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot